Smitha Yerrum recognized by Influential Women for biotech leadership

Smitha Yerrum, a clinical sample manager in Boston, has been named an Influential Woman of 2026 for her work on LIMS development, lab operations and data-driven biopharma infrastructure. The recognition highlights her role in building sample-tracking systems, improving lab throughput and pushing human oversight alongside AI use in clinical research.

Why it matters: - Clinical sample management sits at the center of clinical trial integrity, where chain of custody and data accuracy affect patient samples and research results. - Yerrum’s work focuses on building lab systems that support compliance, operational continuity and faster research workflows in biotech and biopharma. - Her recognition reflects growing attention to leaders who can combine lab operations, digital systems and AI-assisted efficiency.

What happened: - Influential Women named Smitha Yerrum an Influential Woman of 2026. - Yerrum works as a Clinical Sample Manager in Boston, Massachusetts. - Yerrum has more than 18 years of experience in biotech and biopharma operations, with a background in cancer research and molecular biology. - The recognition highlights her leadership in Laboratory Information Management Systems development and clinical trial sample management.

The details: - Yerrum has led the strategic design and implementation of Laboratory Information Management Systems, or LIMS, to support end-to-end sample tracking. - Her systems work is aimed at preserving chain of custody for every patient sample. - Her career includes work at MD Anderson Cancer Center, Dana-Farber Cancer Institute and Van Andel Research Institute. - Yerrum helped set up and launch Shape Therapeutics’ Boston headquarters, a 25,000-square-foot facility. - She used Lean and 5S methods to reach 100% GxP-aligned operational readiness on schedule. - Her lab workflow improvements have increased research throughput by up to 90% while maintaining operational continuity. - Yerrum holds two Master of Science degrees. - She completed training through Harvard Law School’s Zero-L program and Y Combinator Startup School. - She also studied at NYU Tisch School of the Performing Arts, where she explored scriptwriting and editing. - Yerrum said communication is central to her professional approach. - She said open communication helps people share ideas and contribute to team success. - Yerrum has learned programming, AI and machine learning. - She received a workplace AI Innovation Award for using AI tools to improve data reconciliation from archived files. - The AI project took two days to complete, versus about one week traditionally. - Yerrum said human judgment remains essential for scientific integrity and compliance. - Yerrum serves as a keynote speaker for Lab Manager. - Her featured webinar series includes “How to Lead a Biopharma Lab” and “How to Lead an Academic Lab.” - Through her Influential Women profile, Yerrum shares more about her background and work.

Between the lines: - The profile frames Yerrum as a hybrid operator: part lab systems builder, part process leader and part communicator. - The emphasis on AI is not about replacing lab staff. It is about speeding up data work while keeping humans in control of regulated processes. - Her multidisciplinary training suggests the industry is valuing leaders who can translate technical requirements into organized, compliant operations.

What's next: - Yerrum is likely to keep focusing on clinical sample operations, lab systems and workforce mentoring. - Her public speaking and webinar work position her to keep influencing how labs think about operations, technology and leadership. - The profile suggests continued emphasis on combining automation with oversight in clinical research settings.

The bottom line: - Smitha Yerrum’s recognition underscores how biotech leadership is increasingly defined by operational rigor, digital systems expertise and the ability to keep humans in the loop.